HMO consists of five structural units: an acid monosaccharide, sialic acidor N-acetylneuraminic acid; three monosaccharides, namely D-glucose (Glc), L-fucose (Fuc), and D-galactose (Gal); and an amino sugar, N-acetylglucosamine (GlcNAc). The reducing end structures of these units all contain a lactose moiety. HMOs can be divided into three categories: fucosylated oligosaccharides, sialylated oligosaccharides, and core oligosaccharides.
CD BioGlyco is devoted to continuously optimizing the technology using our expertise for HMO production and supplies products on both bulk industry and R&D laboratory bulk industry scales. We will continue developing better solutions for [[ https://www.bioglyco.com/hmo-production-service.html | HMO production ]] to meet application challenges based on client requirements.